Show simple item record

dc.contributor.authorWorld Health Assembly, 62
dc.coverage.spatialGenevaen
dc.date.accessioned2011-11-10T10:28:56Z
dc.date.available2011-11-10T10:28:56Z
dc.date.issued2009
dc.identifier.govdocA62/14
dc.identifier.urihttps://iris.who.int/handle/10665/2260
dc.descriptionWorld Health Assembly sixty-second session, provisional agenda item 12.9en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subjectPharmeceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Contaminationen
dc.subject.meshFrauden
dc.subject.meshLegislation, Drugen
dc.subject.meshCommerceen
dc.subject.meshInternational Cooperationen
dc.titleCounterfeit medical products: International Medical Products Anti-Counterfeiting Taskforceen
dc.typeGoverning body documentsen
dc.subject.meshqualifiersupply and distributionen
who.relation.languageVersion10665/4186en
who.relation.languageVersion10665/3414en
who.relation.languageVersion10665/3468en
who.relation.languageVersion10665/2564en
who.relation.languageVersion10665/4155en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record